Skip to main content

Table 2 Studies included in the network meta-analysis

From: Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis

Interventions

No of trials

Range(mg/day)

Year of publication

Country

Bedaquiline

2

1200-1600

2009-2012

Brazil, India, Latvia, Peru, Russian Federation, South Africa, Thailand

Delamanid

3

200-400

2012-2013

China, Egypt, Estonia, Japan, Korea, Latvia, Peru, Philippines, Cairo, Masan, United States.

Metronidazole

2

1500

2013

Korea

Moxifloxacin

4

400

2011-2013

Brazil, Korea,China

Levofloxacin

2

600-750

2011-2013

Korea, China